Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Commentary on hepatoblastoma minisymposium

Commentary on hepatoblastoma minisymposium Pediatr Radiol (2006) 36: 175 DOI 10.1007/s00247-005-0076-z MINISYMPOSIUM Bruce Morland Received: 15 November 2005 / Accepted: 15 November 2005 / Published online: 19 January 2006 # Springer-Verlag 2006 Hepatoblastoma treatment has been one of the great success towards greater use of preoperative chemotherapy from stories for paediatric oncology in the past two decades. We other international groups, it can only be hoped that the have seen survival rates increase from 25% to over 80% PRETEXT system becomes the common international during this period of time. As with many children’s cancers language for hepatoblastoma staging, which will allow this has been achieved though effective multidisciplinary direct comparison between studies conducted elsewhere in team (MDT) work and the active recruitment of children the world. into successive clinical trials. Three papers are presented in Accurate preoperative staging is vital to the current the minisymposium published in this journal by represen- SIOPEL clinical trials portfolio where high-risk tumours tatives of three of the components of any classical MDT: a (PRETEXT IV and metastatic) are managed quite differ- radiologist, a surgeon and an oncologist. ently from low-risk tumours (PRETEXT I–III). The thrust The minisymposium provides very much a European for high-risk tumours remains driving http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatric Radiology Springer Journals

Commentary on hepatoblastoma minisymposium

Morland, Bruce
Pediatric Radiology , Volume 36 (3) – Jan 19, 2006
Download PDF
1 page

Commentary on hepatoblastoma minisymposium

Abstract

Pediatr Radiol (2006) 36: 175 DOI 10.1007/s00247-005-0076-z MINISYMPOSIUM Bruce Morland Received: 15 November 2005 / Accepted: 15 November 2005 / Published online: 19 January 2006 # Springer-Verlag 2006 Hepatoblastoma treatment has been one of the great success towards greater use of preoperative chemotherapy from stories for paediatric oncology in the past two decades. We other international groups, it can only be hoped that the have seen survival rates increase from 25% to over 80% PRETEXT...
Loading next page...
 
/lp/springer-journals/commentary-on-hepatoblastoma-minisymposium-kuIh2mQ99e

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2006 by Springer-Verlag
Subject
Medicine & Public Health; Oncology ; Ultrasound; Nuclear Medicine ; Neuroradiology ; Pediatrics ; Imaging / Radiology
ISSN
0301-0449
eISSN
1432-1998
DOI
10.1007/s00247-005-0076-z
pmid
16421741
Publisher site
See Article on Publisher Site

Abstract

Pediatr Radiol (2006) 36: 175 DOI 10.1007/s00247-005-0076-z MINISYMPOSIUM Bruce Morland Received: 15 November 2005 / Accepted: 15 November 2005 / Published online: 19 January 2006 # Springer-Verlag 2006 Hepatoblastoma treatment has been one of the great success towards greater use of preoperative chemotherapy from stories for paediatric oncology in the past two decades. We other international groups, it can only be hoped that the have seen survival rates increase from 25% to over 80% PRETEXT system becomes the common international during this period of time. As with many children’s cancers language for hepatoblastoma staging, which will allow this has been achieved though effective multidisciplinary direct comparison between studies conducted elsewhere in team (MDT) work and the active recruitment of children the world. into successive clinical trials. Three papers are presented in Accurate preoperative staging is vital to the current the minisymposium published in this journal by represen- SIOPEL clinical trials portfolio where high-risk tumours tatives of three of the components of any classical MDT: a (PRETEXT IV and metastatic) are managed quite differ- radiologist, a surgeon and an oncologist. ently from low-risk tumours (PRETEXT I–III). The thrust The minisymposium provides very much a European for high-risk tumours remains driving

Journal

Pediatric Radiology – Springer Journals

Published: Jan 19, 2006

There are no references for this article.